Effect of outside influences on the therapeutic benefits of botulinum toxin injections
Objective: The purpose of this project is to determine if outside influences or stressors have an effect on the therapeutic benefit of botulinum toxin injections…International differences in the baseline characteristics and clinical management of cervical dystonia patients presenting for botulinum toxin treatment in routine practice
Objective: To characterise the demographic and clinical characteristics of cervical dystonia (CD) patients presenting for routine treatment with botulinum neurotoxin-A (BoNT-A) across different regions. Background:…Efficacy of 4845 botulinum toxin (BoNT) treatment cycles, and clinical strategies after a failed cycle
Objective: To explore 1) relationship between peak benefit and Duration of Adequate Response (DAR) after BoNT, 2) frequency & causes of secondary Treatment Failure (TF),…Endoscopic-guided injection of botulinum toxin into the longus capitis muscle and into the obliquus superior part of the longus colli muscle in dystonic antecaput
Objective: Cervical dystonia is the most commonly described dystonia. Since examinations of the muscle using imaging techniques were started [1], the classification of the phenomenological…Botulinum toxin type A therapy for blepharospasm – Update of a Cochrane systematic review and meta-analysis
Objective: To compare the effects of botulinum toxin type A (BtA) versus placebo in blepharospasm. Background: This is an update of a Cochrane systematic review.…Multicentre retrospective chart review of patients treated with incobotulinumtoxinA to evaluate sustained efficacy and tolerability in converted and de-novo conditions
Objective: This study aimed to determine whether IncobotulinumtoxinA (IBTX) provides sustained efficacy as a treatment modality patients in both de-novo patients and patients converted from…Botulinum toxin type B therapy for cervical dystonia – 2015 update of a Cochrane systematic review and meta-analysis
Objective: To compare the effects of botulinum toxin type B (BtB) versus placebo in cervical dystonia (CD). Background: This is an update of a Cochrane…AbobotulinumtoxinA for cervical dystonia: International treatment patterns
Objective: To characterise international dosing practice for abobotulinumtoxinA (Dysport®, ABO) for cervical dystonia (CD) in a large observational study. Background: The safety and efficacy of…Botulinum neurotoxins type A versus B for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To update a Cochrane review comparing botulinum neurotoxin type A (BtA) to type B (BtB) in adults with cervical dystonia (CD). Background: This is…How satisfied are cervical dystonia patients with their botulinum toxin treatment? Findings from an international observational study
Objective: Evaluate patient satisfaction with botulinum neurotoxin-A (BoNT-A) treatment over an injection cycle in routine practice. Background: Benefits of BoNT-A injection in cervical dystonia (CD)…